Drugs on EMI

People in an extremely backward Haryana town, where almost every fifth person has hepatitis C, are forced to seek treatment on EMIs

Activists demand access to affordable oral hepatitis drugs

Giving patents to foreign-made medicines will add to patients’ woes, they urge   

Hepatitis afflicts many HIV/AIDS patients, but there is no policy for them

Health ministry and AIDS control body keep shifting responsibility; no statistics available on patients with co-infection

World Hepatitis Day: Who can pay for hepatitis C treatment?

Selling price of HCV drugs far higher than production cost, all because of pro-industry patent regime

Maths of Gilead's hepatitis C drug

Why US firm's super expensive drug sofosbuvir costs so much and how it can be made at a tenth of current price

US authority approves more efficacious hepatitis C drug

Sofosbuvir's prohibitive cost will put it out of reach of most patients in developing countries, including India

24 die of jaundice in Maharashtra's textile city

Ichalkaranji does not have the facilities to care for the 3,500 persons taken ill by Hepatitis E

Most Central Asian countries have broken food safety control systems, finds paper

Severe food safety challenges in CAREC member countries; overlaps in mandates and institutional conflicts in China

Patent claim on hepatitis C drug questioned in many countries

With hepatitis C killing at least 700,000 people every year, civil society has strengthened efforts to make the drug accessible